| pubmed-article:19810097 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19810097 | lifeskim:mentions | umls-concept:C0026769 | lld:lifeskim |
| pubmed-article:19810097 | lifeskim:mentions | umls-concept:C2936411 | lld:lifeskim |
| pubmed-article:19810097 | lifeskim:mentions | umls-concept:C0271510 | lld:lifeskim |
| pubmed-article:19810097 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:19810097 | pubmed:dateCreated | 2009-10-14 | lld:pubmed |
| pubmed-article:19810097 | pubmed:abstractText | There is substantial evidence supporting the role of interferon (IFN)-gamma-producing T helper (T(H)) 1 and interleukin (IL)-17-expressing T(H)17 lymphocytes in multiple sclerosis (MS) and its animal model, experimental allergic encephalomyelitis (EAE). However, to date little is known about the potential cooperative interplay between these 2 cytokines. In the current study, we sought to evaluate the frequency of IFN-gamma-expressing T(H)17 lymphocytes in MS and EAE, and study their recruitment into the central nervous system (CNS). | lld:pubmed |
| pubmed-article:19810097 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19810097 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19810097 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19810097 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19810097 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19810097 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19810097 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19810097 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19810097 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:19810097 | pubmed:issn | 1531-8249 | lld:pubmed |
| pubmed-article:19810097 | pubmed:author | pubmed-author:PratAlexandre... | lld:pubmed |
| pubmed-article:19810097 | pubmed:author | pubmed-author:DuquettePierr... | lld:pubmed |
| pubmed-article:19810097 | pubmed:author | pubmed-author:ArbourNathali... | lld:pubmed |
| pubmed-article:19810097 | pubmed:author | pubmed-author:IferganIgalI | lld:pubmed |
| pubmed-article:19810097 | pubmed:author | pubmed-author:BernardMoniqu... | lld:pubmed |
| pubmed-article:19810097 | pubmed:author | pubmed-author:KebirHaniaH | lld:pubmed |
| pubmed-article:19810097 | pubmed:author | pubmed-author:PoirierJoséeJ | lld:pubmed |
| pubmed-article:19810097 | pubmed:author | pubmed-author:AlvarezJorge... | lld:pubmed |
| pubmed-article:19810097 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19810097 | pubmed:volume | 66 | lld:pubmed |
| pubmed-article:19810097 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19810097 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19810097 | pubmed:pagination | 390-402 | lld:pubmed |
| pubmed-article:19810097 | pubmed:dateRevised | 2010-8-26 | lld:pubmed |
| pubmed-article:19810097 | pubmed:meshHeading | pubmed-meshheading:19810097... | lld:pubmed |
| pubmed-article:19810097 | pubmed:meshHeading | pubmed-meshheading:19810097... | lld:pubmed |
| pubmed-article:19810097 | pubmed:meshHeading | pubmed-meshheading:19810097... | lld:pubmed |
| pubmed-article:19810097 | pubmed:meshHeading | pubmed-meshheading:19810097... | lld:pubmed |
| pubmed-article:19810097 | pubmed:meshHeading | pubmed-meshheading:19810097... | lld:pubmed |
| pubmed-article:19810097 | pubmed:meshHeading | pubmed-meshheading:19810097... | lld:pubmed |
| pubmed-article:19810097 | pubmed:meshHeading | pubmed-meshheading:19810097... | lld:pubmed |
| pubmed-article:19810097 | pubmed:meshHeading | pubmed-meshheading:19810097... | lld:pubmed |
| pubmed-article:19810097 | pubmed:meshHeading | pubmed-meshheading:19810097... | lld:pubmed |
| pubmed-article:19810097 | pubmed:meshHeading | pubmed-meshheading:19810097... | lld:pubmed |
| pubmed-article:19810097 | pubmed:meshHeading | pubmed-meshheading:19810097... | lld:pubmed |
| pubmed-article:19810097 | pubmed:meshHeading | pubmed-meshheading:19810097... | lld:pubmed |
| pubmed-article:19810097 | pubmed:meshHeading | pubmed-meshheading:19810097... | lld:pubmed |
| pubmed-article:19810097 | pubmed:meshHeading | pubmed-meshheading:19810097... | lld:pubmed |
| pubmed-article:19810097 | pubmed:meshHeading | pubmed-meshheading:19810097... | lld:pubmed |
| pubmed-article:19810097 | pubmed:meshHeading | pubmed-meshheading:19810097... | lld:pubmed |
| pubmed-article:19810097 | pubmed:meshHeading | pubmed-meshheading:19810097... | lld:pubmed |
| pubmed-article:19810097 | pubmed:meshHeading | pubmed-meshheading:19810097... | lld:pubmed |
| pubmed-article:19810097 | pubmed:meshHeading | pubmed-meshheading:19810097... | lld:pubmed |
| pubmed-article:19810097 | pubmed:meshHeading | pubmed-meshheading:19810097... | lld:pubmed |
| pubmed-article:19810097 | pubmed:meshHeading | pubmed-meshheading:19810097... | lld:pubmed |
| pubmed-article:19810097 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19810097 | pubmed:articleTitle | Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis. | lld:pubmed |
| pubmed-article:19810097 | pubmed:affiliation | Neuroimmunology Research Unit, Center for Excellence in Neuromics, Montreal, Quebec, Canada. | lld:pubmed |
| pubmed-article:19810097 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19810097 | pubmed:publicationType | In Vitro | lld:pubmed |
| pubmed-article:19810097 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19810097 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19810097 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19810097 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19810097 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19810097 | lld:pubmed |
